The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
New Class of Polymers for the Delivery of Macromolecular Therapeutics
Abstract
Cationic polymers show promise for the in vitro and in vivo delivery of macromolecular therapeutics. Known cationic polymers, e.g., poly(L)lysine (PLL) and polyethylenimine (PEI), have been employed in native and modified forms for the delivery of plasmid DNA (pDNA) and reveal varying levels of toxicity. Here, we report the preparation of a new class of cationic polymers that are specifically designed to deliver macromolecular therapeutics. Linear, cationic, beta-cyclodextrin (beta-CD)-containing polymers (CD-polymers) are synthesized by copolymerizing difunctionalized beta-CD monomers (AA) with other difunctionalized comonomers (BB) such that an AABBAABB product is formed. The beta-CD polymers are able to bind approximately 5 kbp pDNA above polymer to DNA (+/-) charge ratios of 1.5, compact the bound pDNA into particles of approximately 100-150 nm in size at charge ratios above 5+/-, and transfect cultured cells at charge ratios above 10+/-. In vitro transfections with the new beta-CD-polymers are comparable to the best results obtained in our hands with PEI and Lipofectamine. Some cell line-dependent toxicities are observed for serum-free transfections; however, no toxicity is revealed at charge ratios as high as 70+/- in transfections conducted in 10% serum. Single IV and IP doses as high as 200 mg/kg in mice showed no mortalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.
Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y. J., Border, R., Ramsey, P., Martin, M., & Felgner, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41980-6 · Cited by 1,312
(1996) · Elsevier eBooks · doi:10.1016/b978-0-12-342335-1.x5000-3 · Cited by 1,016
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Böttcher, C., Endisch, C., Fuhrhop, J.-H., Catterall, C., & Eaton, M. (1998) · Journal of the American Chemical Society · doi:10.1021/ja971047w · Cited by 250
Lavigne, J. J., Savoy, S., Clevenger, M. B., Ritchie, J. E., McDoniel, B., Yoo, S.-J., Anslyn, E. V., McDevitt, J. T., Shear, J. B., & Neikirk, D. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9743405 · Cited by 230
Artificial self-assembling systems for gene delivery
Felgner, P. L. (1996) · American Chemical Society eBooks · Cited by 66
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Self-citationDelivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Self-citationDegradable poly (β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA
Lynn, D. M., & Langer, R. (2000) · Journal of the American Chemical Society · doi:10.1021/ja0015388 · Cited by 924
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Cyclodextrin-based supramolecular systems for drug delivery: Recent progress and future perspective
Zhang, J., & Ma, P. X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.001 · Cited by 836
Li, J., & Loh, X. J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.011 · Cited by 787
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
Self-citationCationic polymers and their therapeutic potential
Samal, S. K., Dash, M., Van Vlierberghe, S., Kaplan, D. L., Chiellini, E., van Blitterswijk, C., Moroni, L., & Dubruel, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35094g · Cited by 714
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Self-citationMidoux, P., Pichon, C., Yaouanc, J., & Jaffrès, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00288.x · Cited by 548
Cancer nanomedicines: So many papers and so few drugs!
Venditto, V. J., & Szoka, F. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 537
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Hydrophobic modifications of cationic polymers for gene delivery
Liu, Z., Zhang, Z., Zhou, C., & Jiao, Y. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.007 · Cited by 432
Chen, C.-C., Lin, Y.-P., Wang, C.-W., Tzeng, H.-C., Wu, C.-H., Chen, Y.-C., Chen, C.-P., Chen, L.-C., & Wu, Y.-C. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0570180 · Cited by 424
Cyclodextrin based novel drug delivery systems
Vyas, A., Saraf, S., & Saraf, S. (2008) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-008-9456-y · Cited by 412
The great escape: how cationic polyplexes overcome the endosomal barrier
Bus, T., Traeger, A., & Schubert, U. S. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00967h · Cited by 409
Cyclodextrin-based gene delivery systems
Mellet, C. O., Fernández, J. M. G., & Benito, J. M. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00019a · Cited by 393
Anticancer Polymeric Nanomedicines
Tong, R., & Cheng, J. (2007) · Polymer Reviews · doi:10.1080/15583720701455079 · Cited by 310
Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery
Pandey, A. P., & Sawant, K. K. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.07.066 · Cited by 300
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Moore, N. M., Sheppard, C. L., Barbour, T. R., & Sakiyama‐Elbert, S. E. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1234 · Cited by 63
Metadata
- Authors
- Gonzalez, H., Hwang, S. J., & Davis, M. E.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-09-24
- Volume
- 10
- Issue
- 6
- Pages
- 1068-1074
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2031123577
- Cited by
- 312
- References
- 6
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.